The Commodity Futures Trading Commission filed a motion to dismiss Chicago Mercantile Exchange's lawsuit challenging the agency's approval of digital-asset perpetual futures, arguing CME lacks legal standing to sue.
The CFTC contends in its filing that CME has no plausible competitive injury because CME itself can list digital-asset perpetual futures as a Designated Contract Market. The standing argument cuts to the core of the case: if CME has the regulatory pathway to offer the same products, the agency says, CME cannot credibly claim harm from their existence elsewhere.
CME sued the CFTC in June 2026 after the agency approved perpetual futures contracts on Bitcoin and Ethereum through Kalshi, a prediction market platform operating under the Commodity Exchange Act's exemption for certain binary options. CME, which operates the world's largest derivatives exchange, argued the approval violated the CEA and the Administrative Procedure Act by circumventing the Designated Contract Market framework that governs CME's own listings. CME holds roughly 70 percent of global regulated futures volume and had no competing product in digital-asset perpetuals when Kalshi's contracts went live.
The CFTC's standing argument rests on a procedural threshold question: whether CME has suffered an injury-in-fact distinct from ordinary market competition. The agency takes the position that a competitor's inability to capture market share is not a cognizable legal harm under Article III of the Constitution.
Kalshi's perpetual futures launch marked the first time the CFTC had authorized digital-asset derivatives outside the CME's traditional derivatives framework. The contracts allow users to take long or short positions on Bitcoin and Ethereum with up to 20x margin requirements. CME has petitioned regulators to permit its own digital-asset perpetuals product but has not received approval.
The case pits CME's argument that CFTC approval bypassed statutory safeguards against the agency's position that it acted within its delegated authority. If the motion to dismiss succeeds, the lawsuit ends before the merits phase. If it fails, discovery and briefing on the Administrative Procedure Act claims proceed.
The court docket shows the motion was filed on September 2, 2026. CME will file a response brief under the standard civil procedure schedule. The outcome hinges on whether the federal judge accepts the CFTC's threshold argument or permits CME to proceed to challenge the substantive legality of the agency's action.
